propamidine isetionate
Trade name: Brolene
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Aug 13, 2017 (NCT03274895)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
N=C(N)c1ccc(OCCCOc2ccc(C(=N)N)cc2)cc1- Mol. weight
- 312.37 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL23013 ↗
Also known as
- panamidin
- propamidine
- propamidine
- propamidine
- propamidine
- propamidine
- propamidine dihydrochloride
- propamidine hcl
- propamidine hydrochloride
- propamidine isethionate
- propamidine isetionate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03274895 | Phase 3 | Aug 13, 2017 | Moorfield's Hospital London, SIFI SpA |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Moorfield's Hospital London | Academic/Hospital | 1 | 0 | 1 | 2017 |
| SIFI SpA | For profit | 1 | 1 | 1 | 2017 |
2 organizations
Page 1 / 1